Butamax receives patent for DHAD enzyme used in producing isobutanol
August 20, 2012
| Isabel Lane
In Delaware, Butamax has received a US patent ‘878 for its enzyme production as it pertains to the production of isobutanol. The company filed an additional lawsuit against Gevo last week for infringement upon this patent as it demonstrated that Butamax innovated the technology for isobutanol production years before Gevo patents were filed. “Butamax was first to identify the superior activity of these DHAD enzymes for the production of isobutanol,” said Paul Beckwith, Butamax CEO, “and we are pleased to add this patent to our extensive intellectual property portfolio.” These DHAD enzymes perform the third of the five steps in the engineered isobutanol biosynthetic pathway invented by Butamax.
